USPSTF Again Recommends Against Postmenopausal Hormone Therapy for Chronic Disease Prevention
The task force suggests no change from its 2005 recommendations.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Activate your free online account for full access to all site content and features.
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)